AUPH News and Press, Aurinia Pharmaceuticals Inc From 11/07/19

- Data support differentiation of voclosporin as a potential best-in-class CNI - Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multip...

- Voclosporin ophthalmic solution (VOS) AUDREY trial results anticipated in the second half of 2020 – Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advanc...

Thesis to Investment: The likelihood that Aurinia Pharmaceuticals Inc.'s ( AUPH ) phase III trial, AURORA, succeeds is exceedingly low. The thesis to investment relies on a few vital prerequisites. The first being that the standard of care (SoC) for induction treatment of lupus nephritis ((L...

Shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) , a clinical-stage biopharmaceutical company focused on rare diseases, were up 10% as of 11:05 a.m. EDT on Tuesday after management issued a press release that contained upbeat clinical and financial news. Management wanted to get three main...

- AURORA Phase 3 results with voclosporin for the treatment of lupus nephritis remain on track to be reported by the end of the fourth quarter 2019 - - Company provides commentary regarding at-the-market (“ATM”) facility - - AURORA II continuation study progressing a...

Gainers:  Westwater Resources (NASDAQ: WWR ) +108% . TDH Holdings (NASDAQ: PETZ ) +74% . Reata Pharmaceuticals (NASDAQ: RETA ) +60% . Ra Medical Systems (NYSE: RMED ) +25% . Aphria (NYSE: APHA ) +25% . Abeona Therapeutics (NASDAQ: ABEO ) +25% . CannTrust Holdings (NYSE: CTST ) ...

Gainers : Ra Pharmaceuticals, Inc. (NASDAQ: RARX ) +100% . OncoSec Medical Incorporated (NASDAQ: ONCS ) +34% . ProPetro Holding Corp. (NYSE: PUMP ) +22% . Mereo BioPharma Group plc (NASDAQ: MREO ) +21% . Bed Bath & Beyond (NASDAQ: BBBY ) +20% . Caladrius Biosciences (NASDAQ: CLBS ...

Lupus nephritis ((LN)) is an inflammation of the kidney caused by an autoimmune disease called systemic lupus erythematosus (SLE) which affects mostly women. It is classified by different disease progression stages, and the symptoms are usually quite systemic, including fever, proteinuria, ede...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (the “ Company ”) today announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will participate in a fireside chat at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2, 2019 at 1:1...

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late- stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that it has entered into an Open Market Sales Agreement wi...